EANS-Voting Rights: AGENNIX AG / Release according to article 26, section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution
Further inquiry note: Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free ...
mehr